Tag: SCiStar
Asterias Biotherapeutics Receives FDA Clearance to Enroll C-4 Patients in SCiStar Study
Ability to enroll patients with second most common cervical spinal cord injury broadens eligible population for SCiStar study and future trials
FREMONT, Calif., July 10,...